中文

Press Releases

Bermoxel® (Praziquantel 600 mg) Now Available Across All 27 EU Member States Amid Restricted Biltricide® Availability | BioPharma Dive

Amid supply restrictions of Biltricide®, Medochemie's Bermoxel® (praziquantel 600 mg) is now available across all 27 EU member states. Manufactured by Medochemie, it is the only locally authorized supplier of praziquantel 600 mg tablets in Europe. The supply network covers Germany, Austria, the Netherlands, Belgium, Luxembourg, Greece, Cyprus, and 20 other member states.

Press Releases
Healthcare Delivery Enters a New Era as Prefilled Syringes Gain Industry Attention | BioPharma Dive

Prefilled syringes are becoming an important innovation direction in medical drug delivery due to standardized dosing, simplified administration processes, and reduced preparation steps. Based on information released in August 2026, this article analyzes their role in patient safety, clinical efficiency, pharmaceutical packaging and manufacturing, and future development trends.

Press Releases
Bioforum The Data Masters Expands Global Footprint with New Office and Global Capability Center in Bangalore, India | BioPharma Dive

Bioforum The Data Masters announces the opening of a new office and Global Capability Center (GCC) in Bengaluru, India, led by Dr. Santhosh Kumar, who brings over 24 years of industry experience. The center will integrate core capabilities such as clinical data management and statistical programming to support global clinical trial projects, with plans to significantly expand the team over the next year.

Press Releases
Allegheny Health Network and The START Center for Cancer Research Announce Strategic Collaboration to Expand Patient Access to Early-Phase Cancer Trials | BioPharma Dive

Allegheny Health Network (AHN) and the START Center for Cancer Research announced a strategic collaboration to establish a new START early-phase clinical trial site within AHN's Allegheny General Hospital, aiming to expand access to early-phase oncology trials for patients in Western Pennsylvania. The collaboration will integrate START's community-based early-phase trial expertise with AHN's network of cancer specialists, enabling patients to participate in trials within their existing care pathways.

Press Releases

Our partners